cgp 54626 has been researched along with 2-amino-5-phosphonovalerate in 3 studies
Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (2-amino-5-phosphonovalerate) | Trials (2-amino-5-phosphonovalerate) | Recent Studies (post-2010) (2-amino-5-phosphonovalerate) |
---|---|---|---|---|---|
57 | 0 | 16 | 4,393 | 1 | 539 |
Protein | Taxonomy | cgp 54626 (IC50) | 2-amino-5-phosphonovalerate (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.29 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.29 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortez, MA; Eubanks, JH; Han, H; Leschenko, Y; Perez Velazquez, JL; Snead, OC; Stewart, LS; Wu, Y | 1 |
Chavis, P; Farrugia, F; Garenne, A; Le Masson, G; Manzoni, OJ; Marsicano, G; Piet, R | 1 |
Crunelli, V; David, F; Lambert, RC; Leresche, N | 1 |
3 other study(ies) available for cgp 54626 and 2-amino-5-phosphonovalerate
Article | Year |
---|---|
Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Autoradiography; Cognition Disorders; Disease Models, Animal; Electric Stimulation; Electroencephalography; Epilepsy, Absence; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Long-Term Potentiation; Maze Learning; Mice; Mice, Transgenic; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Phenotype; Protein Binding; Receptors, GABA-B; Tritium; Valine | 2009 |
State-dependent, bidirectional modulation of neural network activity by endocannabinoids.
Topics: 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Benzothiadiazines; Brain; Cannabinoid Receptor Modulators; Cells, Cultured; Electric Stimulation; Endocannabinoids; Excitatory Amino Acid Antagonists; GABA Antagonists; In Vitro Techniques; Mice; Mice, Transgenic; Nerve Net; Neural Inhibition; Neurons; Organophosphorus Compounds; Picrotoxin; Piperidines; Potassium Channel Blockers; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sodium Channel Blockers; Tetrodotoxin; Valine | 2011 |
Dynamic Analysis of the Conditional Oscillator Underlying Slow Waves in Thalamocortical Neurons.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzamides; Calcium; Calcium Channel Blockers; Cats; Cerebral Cortex; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; Geniculate Bodies; In Vitro Techniques; Membrane Potentials; Models, Neurological; Neurons; Nonlinear Dynamics; Organophosphorus Compounds; Patch-Clamp Techniques; Piperidines; Pyridazines | 2016 |